Among the 18 primary BC cases, the most common mutations included TP53 (7, 38.9%), RB1 (4, 22.2%), SMAD4 (3, 16.7%), MLH1 (2, 11.1%), PIK3CA (2, 11.1%), and KIT (2, 11.1%). Here, MLH1 is linked to breast cancer.